Frontlight ResearchEarly access
Trial site
Texas Oncology South Austin
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- BioNTech SE1 trial
- Eisai Inc.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Hoffmann-La Roche1 trial
- Pfizer1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026